Jeffrey W. Albers sold $439K of Blueprint Medicines (BPMC)

Executed May 27 2025, disclosed May 29 2025, 2 days later.

Value, as filed

$439K

4,350 sh × $101.02

Executed

May 27 2025

the trade date, as filed

Disclosed

May 29 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JA Jeffrey W. Albers Director profile →

Jeffrey W. Albers (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BPMC. The largest single filing was $2.4M of SYRE (23,000 sh across 3 lots, as filed), executed Aug 7.

The name

BPMC BPMC BPMC · 35 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jeffrey W. Albers in BPMC

BPMCSALE Blueprint Medicines Corp $658K
7,500 sh across 2 lots
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $512K
5,766 sh × $88.80
Exec Mar 5 2025
Filed Mar 17 2025 · 5:30 PM ET † BPMCSALE Blueprint Medicines Corp $1.6M
14,961 sh across 2 lots
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $511K
5,000 sh × $102.28
Exec Jan 13 2025
Filed Jan 15 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $1.3M
15,000 sh across 4 lots
Exec Dec 19 2024
Filed Dec 20 2024 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $510K
5,000 sh × $102.00
Exec Nov 7 2024
Filed Nov 12 2024 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $1.7M
19,702 sh across 2 lots
Exec Sep 9 2024
Filed Sep 11 2024 · 5:30 PM ET